Coactivation of innate immune suppressive cells induces acquired resistance against combined TLR agonism and PD-1 blockade
{{output}}
Immune checkpoint blockade therapy has been successfully applied in clinical settings as a standard therapy for many cancer types, but its clinical efficacy is restricted to patients with immunologically hot tumors. Various strategies to modify the tumor micro... ...
